Sameera Kumar, MD

Dr. Sameera Kumar

Request an Appointment

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Assistant Professor

Specialties

  • Radiation Oncology
  • Thoracic Radiation Oncology

Areas of Expertise

Esophageal Cancer, Mesothelioma, Lung Metastases, Lung Cancer, Thymoma

Distinctions

Educational Background

  • Department of Radiation Oncology, University of Kentucky, Lexington, KY, July 2014-June 2018
    • Resident in Radiation Oncology, 2014-18
    • Chief Resident, 2017-18
  • PhD candidate,  Clinical and Translational Science, University of Kentucky, Lexington, KY,  January 2015- Present
  • MD, West Virginia University School of Medicine, Morgantown, WV, 2013

Certifications

  • American Board of Radiology - Radiation Oncology

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2024
Link to /sites/default/files/styles/patient_story/public/images/patient-stories/Never%20Smokers_Tiffany%20Fagnani.jpg?h=1c77f84e&itok=-H78PxAC

Tiffany Fagnani

  • Lung Cancer

I am 40 years old and currently live in Mechanicsburg, Pennsylvania. Although I work as a case manager for an insurance company now, I was previously employed as a full-time nurse. I have always been a busy person with plenty on my plate, so when I started feeling tired and losing weight, I thought it was caused by the stress of my daily routine.

It wasn’t until July 2017 that I couldn’t ignore my symptoms any longer. When I developed a migraine and felt a tremor in my arm and eye, I knew I was about to lose consciousness. I immediately called 911.

VIEW PATIENT STORY

Selected Publications

Kumar, S; Hall, L; Li, X; Downes, L; Shearer, A; Shelton, B; Gerring, S; McGarry, R. “Comparing Dosimetric Parameters and Clinical outcomes among different SBRT modalities.” IJROBP. Submitted.

Kumar, S; Feddock, J; Li, X; Shearer, A; Hall, L; Shelton, B; Arnold, S; McGarry, M. “An Update of a Prospective Study of SBRT for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer.” IJROBP. Accepted- In Press. DOI: http://dx.doi.org/10.1016/j.ijrobp.2017.07.036

Kumar, S; Higgins, K; McGarry, R. “Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy.” Frontiers of Oncology. Front. Oncol., 04 September 2017.
DOI: https://doi.org/10.3389/fonc.2017.00197

Verma, V; Shostrom, V; Kumar, S; Zhen, W; Hallemeier, C, Braunstein, S; Holland, J; Harkenrider, M; Ishkhanian, A; Neboori, H; Jabbour, S; Attia, A; Lee, P; Alite, F; Walker, J; Stahl, J; Wang, K; Bingham, B; Hadzitheodorou, C; Decker, R; McGarry, R; Simone, C. “Multi-Institutional Experience of Stereotactic Body Radiotherapy for Large (≥5 Centimeter) Non-Small Cell Lung Tumors.” Cancer. September 9, 2016. PubMed

Dong, L; Kudrimoti, M; Irwin, D; Chen, L; Kumar, S; Shang, Y; Huang, C; Johnson, E; Stevens, S; Shelton, B; Yu, G. "Diffuse optical measurements of head and neck tumor hemodynamics for early prediction of chemoradiation therapy outcomes," J. Biomed. Opt. 21(8), 085004 (2016), doi: 10.1117/1.JBO.21.8.085004.

Kumar, SS; Stockham, AL; Chao, ST; Ahluwalia, MS; Suh, JH. “Radiation necrosis: now you see it, now you don’t." Applied Radiology. February 2013.

Additional Publications

Dr. Kumar on PubMed

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...